Eastman Chemical (NYSE: EMN) reported Q2 EPS of $1.60, $0.13 worse than the analyst estimate of $1.73. Revenue for the quarter came in at $2.29 billion versus the consensus estimate of $2.3 billion.

GUIDANCE:

Eastman Chemical sees Q3 2025 EPS of $1.25, versus the consensus of $1.91.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.